Parkinson's disease (PD) is defined as a complex disorder with multifactorial pathogenesis,
yet a more accurate definition could be that PD is not a single entity, but rather a mixture of …

Estimates of the risk of dementia in Parkinson's disease (PDD) vary widely. We aimed to
review the incidence of PDD and in a meta‐analysis estimate the pooled annual incidence …

Parkinson's disease has a large heritable component and genome-wide association studies
have identified over 90 variants with disease-associated common variants, providing deeper …

Emerging evidence is increasingly supporting the use of transcranial photobiomodulation
(tPBM) to improve symptoms of neurodegenerative diseases, including Parkinson's disease …

Parkinson's disease (PD) is a clinically heterogenic disorder characterized by distinct clinical
entities. Most studies on motor deficits dichotomize PD into tremor dominant (TD) or non …

Abstract Device-aided therapies (DAT), which include deep brain stimulation and pump-
based continuous dopaminergic stimulation with either levodopa or apomorphine, are …

Pathological tremor in patients with essential tremor and Parkinsons disease is typically
treated using medication or neurosurgical interventions. There is a widely recognized need …

Apathy is a neurobehavioural symptom affecting Parkinson's disease patients of all disease
stages. Apathy seems to be associated with a specific underlying non-motor disease …

We have recently published the notion of the “vitals” of Parkinson's, a conglomeration of
signs and symptoms, largely nonmotor, that must not be missed and yet often not considered …

Objectives The aim of this review is to provide an overview on prevalence and clinical tools
for the diagnosis of apathy, as well as on neurophysiological and neuroimaging findings …